Before the FDA approved AstraZeneca’s Fasenra, Nucala was the only therapy for treating eosinophilic granulomatosis with ...

NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...

Ossium Health is also running the PRESERVE I trial to evaluate the safety and effectiveness of its deep-frozen bone marrow ...

As part of the acquisition, Organon will acquire psoriasis treatment Vtama, which could soon be approved in atopic dermatitis ...

Gavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to ...

Statistics show incidences of cancer are rising in younger demographics. Tailored therapies offer a solution - if clinical ...

The US FDA has granted approval for MSD’s KEYTRUDA regimen as a first-line treatment for malignant pleural mesothelioma (MPM) ...

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual ...

The agreement will allow Lupin to expand its gastroenterology portfolio in the Indian market. Credit: Orawan Pattarawimonchai ...

The Israeli Ministry of Health granted approval for BeiGene’s TEVIMBRA for unresectable or metastatic oesophageal squamous ...

Kisqali generated $2bn in sales last year, with broader approvals forecasting sales of over $8bn by 2030, per GlobalData ...

A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.